IN8bios Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
–News Direct– By Faith Ashmore, Benzinga IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing…